Press Releases - 2022-02-15

Date	Title	Company
15-Feb-2022	Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer	Intellia and ONK Therapeutics
15-Feb-2022	FIRST CPD STANDARDS FOR HEALTHCARE COMMUNICATIONS PROFESSIONALS	Healthcare Communications Association
15-Feb-2022	ProQR Announces Top-Line Results from Phase 2/3 Illuminate Trial of Sepofarsen in CEP290-mediated LCA10	ProQR Therapeutics N.V.
15-Feb-2022	Immutep granted Australian patent for Eftilagimod Alpha, a soluble LAG-3 protein, in combination with a PD-1 pathway inhibitor	Immutep Limited
15-Feb-2022	Amolyt Pharma to Participate at Three Upcoming Investor Conferences	Amolyt Pharma
15-Feb-2022	Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Prevention of Respiratory Syncytial Virus in Older Adults	Bavarian Nordic A/S
15-Feb-2022	Oxurion Announces New Data on THR-149 Phase 2 Clinical Trial (“KALAHARI”) in DME at the Angiogenesis, Exudation, and Degeneration 2022 Conference	Oxurion NV
15-Feb-2022	mdgroup Appoints Steph Katz as Director of Seacole Health	mdgroup
15-Feb-2022	Dante Labs Issued Genomic Medical Laboratory Authorization in Dubai	Dante Labs
15-Feb-2022	OncoZenge initiates toxicity study and announces modification to the clinical plan	OncoZenge
15-Feb-2022	Newton Biocapital launches a new fund with initial capital commitments of EUR 50 million and target size of EUR 150 million.	Newton Biocapital
15-Feb-2022	OKYO Pharma Limited ("OKYO" or the "Company") - OKYO Pharma announces Successful Completion of a Pre-IND Meeting with the FDA on the Development of OK-101 to Treat Dry Eye Disease	OKYO Pharma Limited
15-Feb-2022	PureTech Founded Entity Akili Interactive Announces Filing of Registration Statement on S-4 in Connection with its Proposed Business Combination with Social Capital Suvretta Holdings Corp. I	PureTech
15-Feb-2022	Janssen Presents New Data Demonstrating the Combination of Niraparib and Abiraterone Acetate Plus Prednisone Significantly Improved Radiographic Progression-Free Survival as a First-Line Therapy in Patients with HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer	Janssen Pharmaceutical Companies of Johnson & Johnson
15-Feb-2022	Intellia and ONK Therapeutics Announce Collaboration to Advance Allogeneic CRISPR-Edited NK Cell Therapies for the Treatment of Patients with Cancer	Intellia Therapeutics, Inc.
15-Feb-2022	Velocity Clinical Research makes tech investments to strengthen patient and client engagement in clinical trials	Velocity Clinical Research
15-Feb-2022	Medidata Opens Access to its Patient Insights Program, Enabling Sponsors and CROs to Leverage Proprietary Patient Centricity by Design Process for Clinical Trials	Medidata
15-Feb-2022	Full-service CRO LINK Medical and Viedoc™ sign a new partnership agreement	LINK Medical and Viedoc
15-Feb-2022	Scientists uncover unique immune cell surveillance mechanism	Francis Crick Institute and King's College London
15-Feb-2022	HAEMATO adds a new generation test device to its portfolio	HAEMATO AG